Abandonment of treatment for childhood cancer: position statement of a SIOP PODC Working Group (original) (raw)
Related papers
Magnitude of Treatment Abandonment in Childhood Cancer
PLOS ONE, 2015
Background Treatment abandonment (TxA) is recognized as a leading cause of treatment failure for children with cancer in low-and-middle-income countries (LMC). However, its global frequency and burden have remained elusive due to lack of global data. This study aimed to obtain an estimate using survey and population data. Methods Childhood cancer clinicians (medical oncologists, surgeons, and radiation therapists), nurses, social workers, and psychologists involved in care of children with cancer were approached through an online survey February-May 2012. Incidence and population data were obtained from public sources. Descriptive, univariable, and multivariable analyses were conducted. Results 602 responses from 101 countries were obtained from physicians (84%), practicing pediatric hematology/oncology (83%) in general or children's hospitals (79%). Results suggested, 23,854 (15%) of 155,088 children <15 years old newly diagnosed with cancer annually in the countries analyzed, abandon therapy. Importantly, 83% of new childhood cancer cases and 99% of TxA were attributable to LMC. The annual number of cases of TxA expected in LMC worldwide (26,166) was nearly equivalent to the annual number of cancer cases in children <15 years expected in HIC (26,368). Approximately two thirds of LMC had median TxA6%, but TxA 6% was reported in high-(9%), upper-middle-(41%), lower-middle-(80%), and low-income countries (90%, p<0.001). Most LMC centers reporting TxA>6% were outside the capital. Lower national income category, higher reliance on out-of-pocket payments, and high prevalence of economic hardship at the center were independent contextual predictors for TxA 6% (p<0.001). Global survival data available for more developed PLOS ONE |
Pediatr Blood Cancer 2015;62:1395–1402, 2015
Background. Treatment-related mortality and abandonment oftherapy are major barriers to successful treatment of childhood acutelymphoblastic leukemia (ALL) in the developing world. Procedure. Acollaboration was undertaken between Instituto Nacional deCancerologia (Bogota, Colombia), which serves a poor patientpopulation in an upper-middle income country, and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center (Boston, USA).Several interventions aimed at reducing toxic deaths and abandon-ment were implemented, including a reduced-intensity treatmentregimen and a psychosocial effort targeting abandonment. Weperformed a cohort study to assess impact. Results. The StudyPopulation comprised 99 children with ALL diagnosed between 2007and 2010, and the Historic Cohort comprised 181 children treatedprior to the study interventions (1995–2004). Significant improve-ments were achieved in the rate of deaths in complete remission(13% to 3%; P ¼ 0.005), abandonment (32% to 9%; P < 0.001), andevent-free survival with abandonment considered an event (47% to65% at 2 years; P ¼ 0.016). However, relapse rate did not improve.Medically unnecessary treatment delays were common, andlandmark analysis revealed that initiating the PIII phase of therapy4 weeks delayed predicted markedly inferior disease-free survival(P ¼ 0.016). Conversely, patients who received therapy withoutexcessive delays had outcomes approaching those achieved in high-income countries. Conclusions. Implementation of a twinningprogram was followed by reductions in abandonment and toxicdeaths, but relapse rate did not improve. Inappropriate treatmentdelays were common and strongly predicted treatment failure. Thesefindings highlight the importance of adherence to treatment schedulefor effective therapy of ALL. Pediatr Blood Cancer 2015;62:1395–1402.# 2015 Wiley Periodicals, Inc.Key words: ALL; outcomes research; pediatric hematology/oncology
Asian Pacific Journal of Cancer Prevention
Introduction: Refusal and abandonment of treatment is often considered as an important reason for poor survival of pediatric cancer patients in developing and underdeveloped countries. In this study we analyze the factors responsible for treatment abandonment and refusal in a Regional Cancer Centre (RCC) in North East India. Material and Methods: All histopathologically or cytologically confirmed cases of childhood cancer from below 15 years of age registered from 1st April, 2010 to 31st March, 2017 were included in this study. Parents or caregivers were interviewed thoroughly and a questionnaire was filled up for analysis of demographic and socioeconomic factors. Modified Kuppuswamy scale was used to measure socioeconomic status. Results: Of 592 patients 161 (27.1%) abandoned therapy and 23 (3.9%) refused treatment. Factors associated with abandonment of treatment included: lower risk if residing in urban areas (Odds ratio [OR] = 0.8333, 95% CI 0.565-1.228; P=0.36) and higher risk with maternal education less than secondary school (OR = 1.357; 95%CI: 0.553-3.326; P=0.505). Low socioeconomic status and age >5yrs were also associated with abandonment of treatment. In a binary logistic regression analysis, male sex [Odds Ratio (OR) = 0.701; 95% CI 0.48-1.01; P=0.062] have lowest risk of abandoning treatment with trend to statistical significance. Conclusion: There is a need for proper definition of the problem of childhood cancer patients so that appropriate policy can be introduced to improve survival by improving treatment compliance.
Pediatric blood & cancer, 2017
Abandonment of treatment is one of the toughest challenges to deal with in pediatric oncology. It leads to unnecessary mortality and morbidity in patients from low- and middle-income countries. The objective of our retrospective study was to determine the prevalence and predictors for abandonment among children with cancer at our hospital in Karachi, Pakistan. We analyzed data on patients younger than 18 years, diagnosed with any malignancy between November 2014 and May 2016. From a total of 821 patients, one hundred and eighty-two (22.2%) patients abandoned treatment at various stages, 92 (11.2%) patients did not initiate treatment at all, and the remaining 90 (11.0%) left during treatment. The gender ratio at registration was skewed toward males but not statistically significant for abandonment. Of 295 registered females, 74 (25.1%) abandoned treatment compared to 108 (20.5%) abandonments among 526 males. In multivariable regression analysis, the type of malignancy, guardian's...
Improvement in treatment abandonment in pediatric patients with cancer in Guatemala
Pediatric blood & cancer, 2017
Treatment refusal and abandonment are major causes of treatment failure for children with cancer in low- and middle-income countries (LMICs), like Guatemala. This study identified risk factors for and described the intervention that decreased abandonment. This was a retrospective study of Guatemalan children (0-18 years) with cancer treated at the Unidad Nacional de Oncología Pediátrica (UNOP), 2001-2008, using the Pediatric Oncology Network Database. Treatment refusal was a failure to begin treatment and treatment abandonment was a lapse of 4 weeks or longer in treatment. The impact of medicina integral, a multidisciplinary psychosocial intervention team at UNOP was evaluated. Cox proportional hazards analysis identified the effect of demographic and clinical factors on abandonment. Kaplan-Meier analysis estimated the survival. Of 1,789 patients, 21% refused or abandoned treatment. Abandonment decreased from 27% in 2001 to 7% in 2008 following the implementation of medicina integra...
BMC Health Services Research
Background Treatment abandonment is one of major reasons for childhood cancer treatment failure and low survival rate in low- and middle-income countries. Ethiopia plans to reduce abandonment rate by 60% (2019–2023), but baseline data and information about the contextual risk factors that influence treatment abandonment are scarce. Methods This cross-sectional study was conducted from September 5 to 22, 2021, on the three major pediatric oncology centers in Ethiopia. Data on the incidence and reasons for treatment abandonment were obtained from healthcare professionals. We were unable to obtain data about the patients’ or guardians’ perspective because the information available in the cancer registry was incomplete to contact adequate number of respondents. We used a validated, semi-structured questionnaire developed by the International Society of Pediatric Oncology Abandonment Technical Working Group. We included all (N = 38) health care professionals (physicians, nurses, and soci...
Treatment abandonment in pediatric patients with acute lymphoblastic leukemia
Boletín médico del Hospital Infantil de México
background.Treatment abandonment is at the end of the spectrum of noncompliance. In children with cancer, whatever the cause that leads to treatment abandonment results in disease progression, recurrence and death. Therefore, the purpose of this study was to determine the frequency of treatment abandonment in pediatric patients with acute lymphoblastic leukemia (ALL) affiliated with the Seguro Popular insurance program. methods. We conducted a systematic review of the literature on the frequency of ALL abandonment and a retrospective cohort study of clinical files of ALL pediatric patients diagnosed during 2001 to 2003 and 2007 to 2009 in seven Mexican states. Results. A review of the literature shows that, among pediatric patients with ALL, treatment abandonment is seen almost only in developing countries and the documented rates may be as high as 64%, but with a diminishing tendency. The abandonment rate for children affiliated with the Seguro Popular insurance program was 13.3% during 2007 to 2009. In contrast, there was a rate of 21.4% of patients who abandoned before their implementation. The highest rates of treatment abandonment were observed during early treatment stages and were seen in hospitals from the states of Hidalgo and Puebla. Conclusions. In comparison to other developing countries, a lower rate of treatment abandonment has been seen in pediatric patients with ALL affiliated with the Seguro Popular insurance program. This observation would be related to the social and economic support provided by this program; however, the rate of abandonment is still high, making it necessary to introduce additional actions in order to improve this issue.
Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru
Pediatric blood & cancer, 2018
Abandonment of treatment is a major cause of treatment failure and poor survival in children with cancer in low- and middle-income countries. The incidence of treatment abandonment in Peru has not been reported. The aim of this study was to examine the prevalence of and factors associated with treatment abandonment by pediatric patients with solid tumors in Peru. We retrospectively reviewed the sociodemographic and clinical data of children referred between January 2012 and December 2014 to the two main tertiary centers for childhood cancer in Peru. The definition of treatment abandonment followed the International Society of Paediatric Oncology, Paediatric Oncology in Developing Countries, Abandonment of Treatment recommendation. Data from 1135 children diagnosed with malignant solid tumors were analyzed, of which 209 (18.4%) abandoned treatment. Bivariate logistic regression analysis showed significantly higher abandonment rates in children living outside the capital city, Lima (f...
Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador
International Journal of Cancer, 2009
Abandonment of therapy is one of the most common causes of treatment failure among children with cancer in low-income countries. Our objectives were to describe the prevalence and predictors of abandonment among such children with cancer in El Salvador. We analyzed data on patients younger than 16 years, diagnosed with any malignancy between January 2001 and December 2003 at the Benjamin Bloom National Children's Hospital, San Salvador. Among 612 patients, 353 were male (58%); the median age at diagnosis was 5.1 years; 59% of patients were diagnosed with leukemia/lymphoma, 28% with solid tumors and 13% with brain tumors. The prevalence of abandonment was 13%. Median time to abandonment was 2.0 (range 0–36) months. In univariate analyses, paternal illiteracy [odds ratio (OR) 3.8, 95% confidence interval (CI) 2.0–7.2; p = 0.001]; maternal illiteracy (OR = 5.1, 95% CI 2.5–10; p < 0.0001); increasing number of household members (OR = 1.2, 95% CI 1.1–1.3; p = 0.004); and low monthly household income (OR per $100 = 0.59, 95% CI 0.45–0.75; p < 0.0001) all significantly increased the risk of abandonment, whereas travel time to hospital did not. In multiple regression analyses, low monthly income and increased number of people in the household were independently predictive of abandonment. In conclusion, in El Salvador, despite the provision of free treatment, socioeconomic variables significantly predict increased risk of abandonment of therapy. Understanding the pathways through which socioeconomic status affects abandonment may allow the design of effective interventions. © 2009 UICC
Pediatric hematology and oncology, 2016
Refusal for treatment and therapy abandonment are important reasons for unfavorable outcome of childhood acute lymphoblastic leukemia (ALL) in resource-poor countries. The present study, conducted on children with ALL whose treatment was abandoned, attempted to track all these children to ascertain the causes and outcome of therapy abandonment/refusal. In order to improve outcome of ALL, measures to prevent abandonment were introduced in the form of treatment subsidies and intensified multistage counseling. Of the 77 (of 418) children abandoning therapy, 17 (22%) refused upfront, whereas the rest abandoned during various phases of chemotherapy. Only 39 (50.6%) of these 77 families could be subsequently contacted. Financial problems, too many dependents at home, and wrong perceptions about cancer led to abandonment in majority. Children abandoning treatment before completion of induction had a significantly shorter survival than who abandoned post induction (P < .0001). Intensifie...